27 Jun 2023 Time to read: 4 MIN Commonwealth claims on the damages undertaking remain a live issue for patentees and generics to consider. The Full Federal Court has dismissed the Commonwealth's appeal, and confirmed the dismissal of the Commonwealth's $325 million damages claim against Sanofi, for PBS cost-savings it says it would have made, but for a preliminary injunction that prevented generic pharmaceutical company, Apotex, from launching its own clopidogrel products.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Deborah
Contact Deborah, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack